Cite
MLA Citation
Yusuf Ilhan et al.. “Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.” International journal of gynecological cancer, vol. 32, no. 4, 2022, pp. 502–507. http://access.bl.uk/ark:/81055/vdc_100153009084.0x00004a